Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

MSD, Astellas Keep Fingers Crossed For EU Fast-Track Status

Jan 30 2019

• By Neena Brizmohun

Ebola — MSD is seeking EU fast-track status for its Ebola vaccine • Source: Shutterstock

Related Content

Fremanezumab Among Latest EU Drug Hopefuls While Patients Speak Up On Pacritinib

Jan 29 2019

New Filings At The EMA

Jan 28 2019

EU Accelerated Assessment Tracker: Nine Definites So Far From 24 Requests In 2018

Jan 10 2019

Merck's View On The Challenges Of Ebola Vaccination In The DRC

Nov 13 2018

EMA's PRIME Scheme: Why Nearly Four Out Of Five Fail To Make The Grade

Aug 18 2016

Related Companies

Astellas Pharma, Inc.

Additional Topics

Europe Approvals Drug Review Regulation BioPharmaceutical Infectious Diseases Cancer

More from Europe

More from Geography

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.